KATHERINE MOCZULSKI: Open Payments
NPI 1740863547 · ROCK SPRINGS, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 17 payments from 7 companies in 2025. Trend: 2023 $215 · 2024 $199 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $104 |
| Lilly USA, LLC | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| PFIZER INC. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
Products named: REXULTI, CAPLYTA, MOUNJARO, BREZTRI, NURTEC ODT, VERQUVO, AIRSUPRA, ZEPBOUND.
Industry payments across WY — which companies pay providers there.
